Literature DB >> 33446272

Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.

Covadonga Bascaran1, Nyawira Mwangi2,3, Fabrizio D'Esposito4, Charles Cleland2, Iris Gordon2, Juan Alberto Lopez Ulloa5, Ranad Maswadi6, Shaffi Mdala7, Jacqueline Ramke2,8, Jennifer R Evans2, Matthew Burton2,9.   

Abstract

BACKGROUND: Vision loss due to diabetic retinopathy can largely be prevented or delayed through treatment. Patients with vision-threatening diabetic retinopathy are typically offered laser or intravitreal injections which often require more than one treatment cycle. However, treatment is not always initiated, or it is not completed, resulting in poor visual outcomes. Interventions aimed at improving the uptake or completion of treatment for diabetic retinopathy can potentially help prevent or delay visual loss in people with diabetes.
METHODS: We will search MEDLINE, Embase, Global Health and Cochrane Register of Studies for studies reporting interventions to improve the uptake of treatment for diabetic retinopathy (DR) and/or diabetic macular oedema (DMO), compared with usual care, in adults with diabetes. The review will include studies published in the last 20 years in the English language. We will include any study design that measured any of the following outcomes in relation to treatment uptake and completion for DR and/or DMO: (1) proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended, (2) proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended, (3) proportion of patients completing treatment for DR and/or DMO among those initiating treatment and (4) number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol. For included studies, we will also report any measures of cost-effectiveness when available. Two reviewers will screen search results independently. Risk of bias assessment will be done by two reviewers, and data extraction will be done by one reviewer with verification of 10% of the papers by a second reviewer. The results will be synthesised narratively. DISCUSSION: This rapid review aims to identify and synthesise the peer-reviewed literature on the effectiveness of interventions to increase uptake and completion of treatment for DR and/or DMO in LMICs. The rapid review methodology was chosen in order to rapidly synthesise the available evidence to support programme implementers and policy-makers in designing evidence-based health programmes and public health policy and inform the allocation of resources. SYSTEMATIC REVIEW REGISTRATION: OSF osf.io/h5wgr.

Entities:  

Keywords:  Diabetic retinopathy; Low- and middle-income countries; Patient acceptance of health care; Treatment outcome

Mesh:

Year:  2021        PMID: 33446272      PMCID: PMC7809874          DOI: 10.1186/s13643-020-01562-9

Source DB:  PubMed          Journal:  Syst Rev        ISSN: 2046-4053


  25 in total

1.  Planning and developing services for diabetic retinopathy in Sub-Saharan Africa.

Authors:  Sophie Poore; Allen Foster; Marcia Zondervan; Karl Blanchet
Journal:  Int J Health Policy Manag       Date:  2014-12-16

Review 2.  Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.

Authors:  Maria José Martinez-Zapata; Arturo J Martí-Carvajal; Ivan Solà; José I Pijoán; José A Buil-Calvo; Josep A Cordero; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2014-11-24

Review 3.  Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.

Authors:  Tien Y Wong; Jennifer Sun; Ryo Kawasaki; Paisan Ruamviboonsuk; Neeru Gupta; Van Charles Lansingh; Mauricio Maia; Wanjiku Mathenge; Sunil Moreker; Mahi M K Muqit; Serge Resnikoff; Juan Verdaguer; Peiquan Zhao; Frederick Ferris; Lloyd P Aiello; Hugh R Taylor
Journal:  Ophthalmology       Date:  2018-05-24       Impact factor: 12.079

4.  Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy.

Authors:  Wen Hua; Sijia Cao; Jing Cui; David Maberley; Joanne Matsubara
Journal:  Can J Ophthalmol       Date:  2017-11       Impact factor: 1.882

5.  Adherence to long-term therapies: evidence for action.

Authors:  Sabina De Geest; Eduardo Sabaté
Journal:  Eur J Cardiovasc Nurs       Date:  2003-12       Impact factor: 3.908

6.  Monotherapy laser photocoagulation for diabetic macular oedema.

Authors:  Eliane C Jorge; Edson N Jorge; Mayra Botelho; Joyce G Farat; Gianni Virgili; Regina El Dib
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

Review 7.  Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.

Authors:  Hemal Mehta; Charles Hennings; Mark C Gillies; Vuong Nguyen; Anna Campain; Samantha Fraser-Bell
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

8.  The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting.

Authors:  Tsukasa Hanemoto; Yusuke Hikichi; Norimasa Kikuchi; Tadahiko Kozawa
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

9.  Rating the certainty in evidence in the absence of a single estimate of effect.

Authors:  M Hassan Murad; Reem A Mustafa; Holger J Schünemann; Shahnaz Sultan; Nancy Santesso
Journal:  Evid Based Med       Date:  2017-03-20

10.  Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting.

Authors:  Anne-Laurence Best; Franck Fajnkuchen; Sylvia Nghiem-Buffet; Typhaine Grenet; Gabriel Quentel; Corinne Delahaye-Mazza; Salomon Y Cohen; Audrey Giocanti-Aurégan
Journal:  J Ophthalmol       Date:  2018-04-18       Impact factor: 1.909

View more
  1 in total

1.  Patient preferences in retinal drug delivery.

Authors:  Brandon Jacobs; Nicholas Palmer; Trupti Shetty; Helen Dimaras; Amir Hajrasouliha; Denis Jusufbegovic; Timothy W Corson
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.